Ameliorative Effects of Resveratrol on Acute Ovarian Toxicity Induced by Total Body Irradiation in Young Adult Rats

Journal of Pediatric and Adolescent Gynecology

Volumn 25, Issue 4, 2012, Pages 262-266

  Simsek, Yavuz ^a   Gurocak, Simay ^a   Turkoz, Yusuf ^a   Akpolat, Nusret ^a   Celik, Onder ^a   Ozer, Ali ^a   Yilmaz, Ercan ^a   Turhan, Ugur ^a   Ozyalin, Fatma ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Ovarian follicle; Oxidative stress; Radiation; Resveratrol

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; RESVERATROL;

ACUTE OVARIAN TOXICITY; ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; FIBROSIS; HISTOPATHOLOGY; LEUKOCYTE; LOW DRUG DOSE; NONHUMAN; OUTCOME ASSESSMENT; OVARY FOLLICLE; PRIORITY JOURNAL; RAT; REPRODUCTIVE TOXICITY; SHAM PROCEDURE; SINGLE DRUG DOSE; WHOLE BODY RADIATION;

ANIMALS; ANTIOXIDANTS; CATALASE; FEMALE; GLUTATHIONE PEROXIDASE; MALONDIALDEHYDE; OVARIAN FOLLICLE; OVARY; RADIATION INJURIES; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; STILBENES;

EID: 84864296515     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2012.04.001     Document Type: Article

References (41)

1. Saito N., Tamura T., Yamamoto N., et al. New strategies for cancer therapy in the 21st century. Cancer Chemother Pharmacol 2001, (48 Suppl 1):S102.
2. Zimmermann K.C., Bonzon C., Green D.R. The machinery of programmed cell death. Pharmacol Ther 2001, 92:57.
3. Núñez M.I., McMillan T.J., Valenzuela M.T., et al. Relationship between DNA damage, rejoining and cell killing by radiation in mammalian cells. Radiother Oncol 1996, 39:155.
4. Burlakova E.B., Mikhailov V.F., Azurik V.K. [The redox homeostasis system in radiation-induced genomic instability]. Radiats Biol Radioecol 2001, 41:489.
5. Di Pietro C., Piro S., Tabbì G., et al. Cellular and molecular effects of protons: apoptosis induction and potential implications for cancer therapy. Apoptosis 2006, 11:57.
6. Bokemeyer C., Schmoll H.J., van Rhee J., et al. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma. Ann Hematol 1994, 68:105.
7. Meirow D., Biederman H., Anderson R.A., et al. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol 2010, 53:727.
8. Gurgan T., Salman C., Demirol A. Pregnancy and assisted reproduction techniques in men and women after cancer treatment. Placenta 2008, (29 Suppl B):152.
9. Armstrong G.T., Chow E.J., Sklar C.A. Alterations in pubertal timing following therapy for childhood malignancies. Endocr Dev 2009, 15:25.
10. Sklar C.A., Mertens A.C., Mitby P., et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 2006, 98:890.
11. Kaya H., Delibas N., Serteser M., et al. The effect of melatonin on lipid peroxidation during radiotherapy in female rats. Strahlenther Onkol 1999, 175:285.
12. Soleas G., Diamandis E.P., Goldberg D.M. Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal 1997, 11:287.
13. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006, 5:493.
14. Bradamante S., Barenghi L., Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 2004, 22:169.
15. Couto M. Laboratory guidelines for animal care. Methods Mol Biol 2011, 770:579.
16. Gross G.H. A technique for sustained synchronization of hamster estrous cycles by hormonal means. Horm Behav 1977, 9:23.
17. Marcondes F.K., Bianchi F.J., Tanno A.P. Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol 2002, 62(4A):609.
18. Ara C., Kirimlioglu H., Karabulut A.B., et al. Protective effect of resveratrol against oxidative stress in cholestasis. J Surg Res 2005, 127:112.
19. Zhang F., Liu J., Shi J.S. Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Eur J Pharmacol 2010, 636:1.
20. Kaya H., Desdicioglu R., Sezik M., et al. Does sphingosine-1-phosphate have a protective effect on cyclophosphamide- and irradiation-induced ovarian damage in the rat model?. Fertil Steril 2008, 89:732.
21. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med 1991, 11:81.
22. Wojcik M., Burzynska-Pedziwiatr I., Wozniak L.A. A review of natural and synthetic antioxidants important for health and longevity. Curr Med Chem 2010, 17:3262.
23. Aebi H., Catalase Methods of Enzymatic Analysis 1974, 673-677. Academic Press, New York. H.U. Bergmeyer (Ed.).
24. Pagia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158.
25. Esterbauer H., Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990, 186:407.
26. Smith B.J., Plowchalk D.R., Sipes I.G., et al. Comparison of random and serial sections in assessment of ovarian toxicity. Reprod Toxicol 1991, 5:379.
27. Erickson G.F., Shimasaki S. The physiology of folliculogenesis: the role of novel growth factors. Fertil Steril 2001, 76(5):943-949.
28. Pedersen T., Peters H. Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil 1968, 17:555.
29. Umegaki K., Aoki S., Esashi T. Whole body X-ray irradiation to mice decreases ascorbic acid concentrations in bone marrow: comparison between ascorbic acid and vitamin E. Free Radic Biol Med 1995, 19:493.
30. Umegaki K., Ichikawa T. Decrease in vitamin E levels in the bone marrow of mice receiving whole-body X-ray irradiation. Free Radic Biol Med 1994, 17:439.
31. Hanoux V., Pairault C., Bakalska M., et al. Caspase-2 involvement during ionizing radiation-induced oocyte death in the mouse ovary. Cell Death Differ 2007, 14:671.
32. Yant L.J., Ran Q., Rao L., et al. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic Biol Med 2003, 34:496.
33. Matzuk M.M., Dionne L., Guo Q., et al. Ovarian function in superoxide dismutase 1 and 2 knockout mice. Endocrinology 1998, 139:4008.
34. Rubiolo J.A., Mithieux G., Vega F.V. Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur J Pharmacol 2008, 591:66.
35. Li Y., Cao Z., Zhu H. Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol Res 2006, 53:6.
36. Kong X.X., Fu Y.C., Xu J.J., et al. Resveratrol, an effective regulator of ovarian development and oocyte apoptosis. J Endocrinol Invest 2011, 34:e374.
37. Tseng S.H., Lin S.M., Chen J.C., et al. Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 2004, 10:2190.
38. Jang M., Cai L., Udeani G.O., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218.
39. In K., Park J., Park H. Resveratrol at high doses acts as an apoptotic inducer in endothelial cells. Cancer Res Treat 2006, 38:48.
40. Bath L.E., Critchley H.O., Chambers S.E., et al. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Br J Obstet Gynaecol 1999, 106:1265.
41. Borek C. Antioxidants and radiation therapy. J Nutr 2004, 134:3207S.